|
|
 |
|
|
|
|
| Your Result on : Balance Sheet |
|
|
|
|
| Concord Biotech Ltd |
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
|
|
|
|
| Book Value (Rs) |
|
| 193.0629905 |
|
|
|
|
|
|
Market Cap
(Rs In Cr.) |
|
| 15,629 |
|
|
|
|
|
|
|
|
|
|
|
|
| Year |
High (Rs) |
Low (Rs) |
Close (Rs) |
P/E High |
P/E Low |
P/E Close |
Mkt Cap.
(Rs In Cr.) |
| Aug 2026 |
1,614.05 |
1,353.35 |
1,449.80 |
71.78 |
58.16 |
62.96 |
15,167.26 |
| Jul 2026 |
1,428.95 |
1,237.70 |
1,420.30 |
62.43 |
53.27 |
61.67 |
14,858.64 |
| Jun 2026 |
1,408.15 |
1,023.05 |
1,277.85 |
62.35 |
42.85 |
55.49 |
13,368.38 |
| May 2026 |
1,233.40 |
1,040.40 |
1,048.85 |
55.18 |
44.81 |
45.54 |
10,972.67 |
| Apr 2026 |
1,162.40 |
987.05 |
1,140.15 |
51.84 |
41.24 |
49.51 |
11,927.82 |
| Mar 2026 |
1,228.15 |
990.00 |
1,015.90 |
54.66 |
41.89 |
44.11 |
10,627.96 |
| Feb 2026 |
1,388.20 |
1,056.75 |
1,221.55 |
43.57 |
27.75 |
36.99 |
12,779.39 |
| Jan 2026 |
1,451.95 |
1,159.00 |
1,174.65 |
46.63 |
34.63 |
35.57 |
12,288.74 |
| Share Prices Of
2025
|
| Dec 2025 |
1,444.35 |
1,318.80 |
1,345.45 |
44.14 |
39.68 |
40.74 |
14,075.59 |
| Nov 2025 |
1,529.90 |
1,382.40 |
1,420.25 |
47.25 |
41.35 |
43.01 |
14,858.12 |
| Oct 2025 |
1,667.00 |
1,429.00 |
1,442.65 |
51.55 |
43.17 |
43.69 |
15,092.46 |
| Sep 2025 |
1,747.95 |
1,524.00 |
1,648.05 |
54.91 |
44.97 |
49.91 |
17,241.27 |
| Aug 2025 |
1,803.60 |
1,479.20 |
1,681.30 |
60.13 |
41.32 |
50.92 |
17,589.12 |
| Jul 2025 |
1,979.20 |
1,720.20 |
1,770.65 |
61.51 |
50.00 |
53.62 |
18,523.87 |
| Jun 2025 |
2,149.90 |
1,757.85 |
1,848.85 |
65.61 |
51.35 |
55.99 |
19,341.97 |
| May 2025 |
1,785.85 |
1,370.05 |
1,746.55 |
55.30 |
40.90 |
52.89 |
18,271.74 |
| Apr 2025 |
1,765.00 |
1,401.00 |
1,524.25 |
54.16 |
37.63 |
46.16 |
15,946.12 |
| Mar 2025 |
1,805.95 |
1,511.35 |
1,676.35 |
56.80 |
45.46 |
50.77 |
17,537.34 |
| Feb 2025 |
2,451.65 |
1,481.45 |
1,495.20 |
95.60 |
52.19 |
53.16 |
15,642.21 |
| Jan 2025 |
2,364.95 |
1,947.10 |
2,172.10 |
88.17 |
66.40 |
77.23 |
22,723.69 |
|
| PREV |
NEXT
|
|
|
|
|
|
|
|
|
|